We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Switch Mechanism Found to Stop Cancer Spread

By LabMedica International staff writers
Posted on 16 Oct 2009
A tiny bit of genetic material with no previously known function may hold the key to stopping the spread of cancer, according to American and Chinese scientists. More...


In the studies, which were published in the September 7-11, 2009, issue of Proceedings of the [U.S.] National Academy of Sciences (PNAS), Dr. Alan Garen, from the department of molecular biophysics and biochemistry at Yale University (New Haven, CT, USA) and his colleague Dr. Xu Song, from Sichuan University (Chengdu, China), clarify how cancer may overcome an organism's natural "stop sign” for cell division. During early development, stem cells give rise to other cells that differentiate into all types of tissue. New cell division and proliferation stop as the organism matures. However, cancer can takeover this process and trigger the uncontrolled cell division that produces cancer tumors.

One process that stops cell proliferation is a family of tumor-suppressor proteins (TSPs) that bind to and block the function of protooncogenes, the genes that have the potential to initiate cancer. Dr. Garen's team, working with lab mice, discovered that an RNA molecule from a region of the genome that does not produce proteins prevents a type of TSP from inactivating these incipient cancer genes. The TSP protein they researched, called PSF, is practically identical in mice and humans, according to Dr. Garen.

The Yale team succeeded in preventing the formation of tumors in mice by either increasing the amount of PSF or decreasing the amount of the noncoding RNA in a cell. "The tumor cell stops proliferating and the tumor regresses in a mouse model of cancer, suggesting that both procedures could be the basis of a clinical protocol,” said Dr. Garen, who is a member of Yale Cancer Center.

Dr. Garen and his colleagues plan to continue their research on the mechanism that regulates the amount of PSF-binding RNA in a cell, which they believe is key to the origins of cancer.

Related Links:
Yale University
Sichuan University


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.